Comparison of the Effectiveness of Grape Seed Extract and Low-Level Laser Therapy in the Management of Dentin Hypersensitivity: A Randomized Controlled Trial

葡萄籽提取物与低强度激光疗法治疗牙本质过敏疗效比较:一项随机对照试验

阅读:1

Abstract

OBJECTIVE: To evaluate the effectiveness of grape seed extract (GSE) and its combination with low-level laser therapy (LLLT) in alleviating pain from dentin hypersensitivity (DH) compared to LLLT alone. METHODS: Patients aged 20-50 years with at least three sensitive teeth in different quadrants and baseline pain scores ≥ 2 on the visual analog scale (VAS) were recruited. Each tooth was randomly allocated to one of three groups: LLLT + placebo, GSE + placebo, or GSE + LLLT. Pain scores were recorded on Days 1, 3, and 7 using cold and air spray tests. RESULTS: The GSE + LLLT group demonstrated the greatest reduction in pain sensitivity, showing a 72.8% decrease for air spray and 59.51% for the cold test at Day 3, compared to the LLLT or GSE groups alone. However, there were no statistically significant differences (P > 0.05) in pain score reduction among the groups at any time point. DISCUSSION: The combination of GSE and LLLT may enhance early pain reduction in DH compared to individual treatments, but the improvement was not statistically significant. GSE presents a potentially feasible and patient-friendly alternative for DH management, warranting further clinical validation. STATISTICAL ANALYSIS USED: Data were collected and analyzed using IBM Statistical Package for the Social Sciences (SPSS) software program, Version 20.0 (IBM, Chicago, Illinois). General linear model-repeated measure ANOVA was carried out to assess the reduction in DH pain score among individual interventions and the comparison between the three interventions. The significance level was set at p < 0.05. CONCLUSION: While GSE combined with LLLT showed the greatest numerical reduction in DH pain scores, the difference was not statistically significant. Further large-scale studies are recommended to confirm the clinical benefits of this combination. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT05927831.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。